Global /India /Healthcare /Drug Manufacturers - General /INNOVACAP
chevron_leftBack
Innova Captab Ltd. logo

Innova Captab Ltd.

INNOVACAP
NSE: INNOVACAP Delayed
752.05INR 3.3%
7.85 USD
As of 6 June 2026, Innova Captab Ltd. has a market cap of $435.32M USD, ranking #16096 globally and #861 in India. It ranks #1448 in the Healthcare sector, and #526 in the Drug Manufacturers - General industry.
Global Rank
16096
Country Rank
861
Sector Rank
1448
Industry Rank
526
Key Stats
Market Cap
$435.32MUSD
41.68B INR
Enterprise Value
$464.36MUSD
44.46B INR
Revenue (TTM)
$156.34MUSD
14.97B INR
EBITDA (TTM)
$22.12MUSD
2.12B INR
Net Income (TTM)
$13.83MUSD
1.32B INR
EBITDA Margin
14%
Profit Margin
8.8%
PE Ratio
31.5
Forward PE
23.6
PS Ratio
2.8
PB Ratio
4.1
EV/EBITDA
20.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Vinay Lohariwala open_in_new
Employees
1,600
Founded
2005
Website
innovacaptab.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
3.3% 0.7% 8.5% 4.6% -10% -18%

News

Loading...

Markets

Exchange Ticker Price
National Stock Exchange of India
MIC: XNSE
PRIMARY
INNOVACAP
Innova Captab Ltd
ISIN: INE0DUT01020
Shares Out.:
57.225M1 Shares Float: 14.83M2
TV:
SA:
YF:
GF:
BA:
MS:
752.05 INR
Bombay Stock Exchange
MIC: XBOM
544067 (INNOVACAP)
Innova Captab Ltd
ISIN: INE0DUT01020
TV:
SA:
YF:
GF:
BA:
MS:
730.75 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Innova Captab Ltd.

Innova Captab Limited, an integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally. The company provides contract development and manufacturing organization services to Indian pharmaceutical companies. It is also offers various generic formulation products, including cephalosporins, proton pump inhibitor, anticholinergic and heparin NSAIDs, analgesics and antipyretic, anticold and antiallergic, antiemetic, antidiabetic, antispasmodic, antifibrinolytic, cardiovascular, antioxidant and vitamins, antihyperuricemia and antigout, fluoroquinolone and macrolide, nootropics and neurotonics/neurotrophics, antiulcerative, antimalarial anxiolytic, anticonvulsant and antipsychotic, bladder and prostate disorder, antifungal, anthelmintic and antiviral, anticholinergic, anti-asthmatic, and bronchodilator products in the form of tablets, capsules, dry syrups, dry powder injection, ointments, and liquid orals. The company sells its branded generic products through a network of distributors and pharmacies, as well as online channels in various e-commerce pharmacy sites. Innova Captab Limited was incorporated in 2005 and is based in Panchkula, India.

Similar Companies

Industry: Drug Manufacturers - General (India)
Name
Market Cap diff.
PE
$44.57B
4.27T INR
10K%
39.1
DIVISLAB
$18.12B
1.73T INR
4K%
70.0
$14.95B
1.43T INR
3K%
63.0
$11.57B
1.11T INR
3K%
19.6
MANKIND
$9.73B
931.67B INR
2K%
52.2
ZYDUSLIFE
$9.57B
916.53B INR
2K%
18.6
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
175K%
38.1
JNJ
$547.28B
126K%
26.4
ABBV
$360.63B
83K%
97.4
$324.68B
256.25B CHF
74K%
19.9
AZN
$289.43B
215.59B GBP
66K%
27.6
NOVN
$277.35B
218.9B CHF
64K%
20.5
chevron_leftBack